Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma

Summary

This pilot phase I trial studies the side effects and the best dose of giving viral therapy to patients with relapsed or refractory multiple myeloma. Viral therapy, such as wild-type reovirus, may be able to kill cancer cells without damaging normal cells.

Timeline

Start

2012-04

Primary completion

2015-02

Completion

2015-02

Drugs

Indications